ANIP

ANI Pharmaceuticals, Inc. · NASDAQ

Performance

+2.85%

1W

+7.78%

1M

+0.48%

3M

+15.82%

6M

+16.97%

YTD

+6.45%

1Y

Profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Technical Analysis of ANIP 2025-06-18

The stock exhibits a strong bullish sentiment with a Moving Average Score of 91 and a Technical Score of 91, indicating robust upward momentum, while the Oscillators Score of 62 suggests a moderately bullish trend. Overall, the combined scores reflect a positive outlook for the stock, signaling potential for continued gains.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of ANIP

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.

Notifications

See All Notifications >